Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors

被引:59
|
作者
Korhonen, LE
Rahnasto, M
Mähönen, NJ
Wittekindt, C
Poso, A
Juvonen, RO
Raunio, H
机构
[1] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
关键词
D O I
10.1021/jm0489713
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to determine the cytochrome P450 1A2 (CYP1A2) inhibition potencies of structurally diverse compounds to create a comprehensive three-dimensional quantitative structure-activity relationship (3D-QSAR) model of CY-P1A2 inhibitors and to use this model to predict the inhibition potencies of an external set of compounds. Fifty-two compounds including naphthalene, lactone and quinoline derivatives were assayed in a 96-well plate format for CY-P1A2 inhibition activity using 7-ethoxyresorufin O-dealkylation as the probe reaction. The IC50 values of the tested compounds varied from 2.3 mu M to over 40 000 mu M. On the basis of this data set, a comparative molecular field analysis (CoMFA) and GRID/GOLPE models were created that yielded novel structural information about the interaction between inhibitory molecules and the CYP1A2 active site. The created CoMFA model was able to accurately predict inhibitory potencies of several structurally unrelated compounds, including selective inhibitors of other cytochrome P450 forms.
引用
收藏
页码:3808 / 3815
页数:8
相关论文
共 50 条
  • [1] Three-dimensional quantitative structure-activity relationship and docking studies on a series of anthocyanin derivatives as cytochrome P450 3A4 inhibitors
    Shityakov, S.
    Broscheit, J.
    Roewer, N.
    Foerster, C.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 305 - 305
  • [2] Structure-activity relationship for human cytochrome P450 substrates and inhibitors
    Lewis, DFV
    Modi, S
    Dickins, M
    DRUG METABOLISM REVIEWS, 2002, 34 (1-2) : 69 - 82
  • [3] Quantitative structure-activity relationships (QSAR) study of flavonoid derivatives for inhibition of cytochrome P450 1A2
    Moon, T
    Chi, MH
    Kim, DH
    Yoon, CN
    Choi, YS
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2000, 19 (03): : 257 - 263
  • [4] Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9
    Jones, JP
    He, MX
    Trager, WF
    Rettie, AE
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (01) : 1 - 6
  • [5] Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome P450 active sites
    Ekins, S
    De Groot, MJ
    Jones, JP
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (07) : 936 - 944
  • [6] Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships
    Liu, Jiawang
    Sridhar, Jayalakshmi
    Foroozesh, Maryam
    MOLECULES, 2013, 18 (12) : 14470 - 14495
  • [7] Theoretical quantitative structure-activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes
    Iori, F
    da Fonseca, R
    Ramos, MJ
    Menziani, MC
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (14) : 4366 - 4374
  • [8] Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ
    J.J. Lozano
    E. López-de-Briñas
    N.B. Centeno
    R. Guigó
    F. Sanz
    Journal of Computer-Aided Molecular Design, 1997, 11 : 395 - 408
  • [9] Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ
    Lozano, JJ
    LopezdeBrinas, E
    Centeno, NB
    Guigo, R
    Sanz, F
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (04) : 395 - 408
  • [10] Three-dimensional modelling of human cytochrome P450 1a2 and its interaction with caffeine and MeIQ
    Lozano, J. J.
    Lopez-de-bri QQ as, E.
    Centeno, N. B.
    Guigo, R.
    Journal of Computer-Aided Molecular Design, 11 (04):